Use of transgenic mice in aging research

ILAR Journal

Volumn 38, Issue 3, 1997, Pages 124-136

  Richardson, Arlan ^a,b,c   Heydari, Ahmad R ^d   Morgan, William W ^b   Nelson, James F ^b   Sharp, Z David ^e,f   Walter, Christi A ^b,g  

^a Aging Research and Education Center   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UTHSCSA ^*

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g Transgenic Animal Facility

Author keywords

[No Author keywords available]

Indexed keywords

MUS MUSCULUS;

EID: 0000870351     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.38.3.124     Document Type: Article

References (77)

1. Balling R, Mutter G, Gruss P, Kessel M. 1989. Craniofacial abnormalities induced by ectopic expression of the homeobox gene Hox-1 in transgenic mice. Cell 58:337-347.
2. Blackwell B, Bucci TJ, Hart RW, Turturro A. 1996. Longevity, body weight, and neoplasia in ad libitum-fed and diet restricted C57BL6 mice fed NIH-31 open formula diet. Toxicol Pathol 23:570-582.
3. Boulikas T. 1993. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J Cell Biochem 52:14-22.
4. Brinster RL, Allen JM, Behringer RR, Gelinas RE, Palmiter RD. 1988. Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci U S A 85:836-840.
5. Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD. 1985. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci U S A 82:4438-4442.
6. Cerami A. 1985. Hypothesis: Glucose as a mediator of aging. J Am Geriatr Soc 33:626-634.
7. Choi T, Huang M, Gorman C, Jaenisch R. 1991. A generic intron increases gene expression in transgenic mice. Mol Cell Biol 11:3070-3074.
8. Coulson PS, Wilson RA. 1989. Portal shunting and resistance to Schistosoma mansoni in 129 strain mice. Parasitology 99:383-389.
9. Cruse JM, Lewis RE Jr. 1994. Transgenics today. Transgene 1:133-134.
10. Denlinger RH, Koestner A, Wechsler W. 1974. Induction of neurogenic tumors in C3HeB/FeJ mice by nitrosourea derivatives: Observations by light microscopy, tissue culture, and electron microscopy. Int J Cancer 13:559-571.
11. Dressier GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Simons LW, Westphal H. 1993. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65-67.
12. Duff K. 1997. Alzheimer trangenic mouse models come of age. TINS 20:279-280.
13. Duhamel-Clerin E, Villarroya H, Mehtali M, Lapie P, Besnard F, Gumpel M, Lachapelle F. 1994. Cellular expression of an HMGCR promoter-CAT fusion gene in transgenic mouse brain: Evidence for a developmental regulation in oligodendrocytes. Glia 11:35-46.
14. Dycaico MJ, Provost GS, Kretz PL, Ransom SL, Moores JC, Short JM. 1994. The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutation Res 307:461-478.
15. Efrat S, Fusco-DeMane D, Lemberg H, Al Emran O, Wang X. 1995. Conditional transformation of a pancreatic b-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 92:3576-3580.
16. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, Hennighausen L. 1996. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science273:1384-1386.
17. Finch CE. 1972. Enzyme activities, gene function, and aging in mammals. Exp Gerontol 7:53-67.
18. Furth PA, Hennighausen L, Baker C, Beatty B, Woychick R. 1991. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res 19:6205-6208.
19. Furth PA, St. Onge L, Böger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A 91:9302-9306.
20. Goodrich JA, Hoey T, Thut CJ, Admon A, Tjian R. 1993. Drosophila TAFii40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell 75:519-530.
21. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Nail Acad Sci U S A 89:5547-5551.
22. Hazzard DG. 1991. Relevance of the rodent model to human aging studies. Neurobiol Aging 12:645-649.
23. Hazzard DG, Bronson RT, McClearn GE, Strong R. 1992. Selection of an appropriate animal model to study aging processes with special emphasis on the use of rat strains. J Gerontol 47:B63-B64.
24. Hazzard DG, Soban J. 1988. Studies of aging using genetically defined rodents: A bibliography. Exp Aging Res 14:59-81.
25. Heynes NE, Kennedy N, Rahmsdorf U, Groner B. 1981. Hormone-responsive expression of an endogenous proviral gene of mammary tumor virus after molecular cloning and gene transfer into cultured cells. Proc Natl Acad Sci U S A 78:2038-2042.
26. Ho YS. 1994. Transgenic models for the study of lung biology and disease. Am J Physiol 266:L319-L353.
27. Hogan B, Beddington R, Costantini F, Lacy E. 1994. Manipulating the Mouse Embryo. Plainview: Cold Spring Harbor Laboratory Press.
28. Liu M, Olson AL, Moye R, Buse JB, Bell GI, Pessin JE. 1992. Expression and regulation of the human GLUT-4 muscle-fat facultative glucose transporter gene in transgenic mice. J Biol Chem 267:11673-11676.
29. Kagan D, Platt J, Logan J, Byrne GW. 1994. Expression of complement regulatory factors using heterologous promoters in transgenic mice. Transplant Proc 26:1242.
30. Knapp JR, Kopchick JJ. 1994. The use of transgenic mice in nutrition research. J Nutr 124:461-468.
31. Koretsky AP. 1992. Investigation of cell physiology in the animal using transgenic technology. Am J Physiol 262:C261-C275.
32. Kothary R, Barten SC, Franz T, Norris ML, Hettle S, Surani MAH. 1991. Unusual cell specific expression of a major human cytomegalovirus immediate early gene promoter-lacZ hybrid gene in transgenic mouse embryos. Mech Ageing Devel 25-31.
33. Lebovitz RM, Zhang H, Vogel H, Cartwright J, Dionne L, Lu N, Huang S, Matzuk MM. 1996. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 93:9782-9787.
34. Lee F, Mulligan R, Berg P, Ringold G. 1991. Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids. Nature 294:228-232.
35. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ. 1995. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376-381.
36. Masoro EJ. 1984. Food restriction and the aging process. J Am Geriatr Soc 32:296-300.
37. Masoro EJ. 1985. Nutrition and aging: A current assessment. J Nutr 115:842-848.
38. Masoro EJ. 1991. Use of rodents as models for the study of "normal aging": Conceptual and practical issues. Neurobiol Aging 12:639-643.
39. Mayo KE, Warren R, Palmiter RD. 1982. The mouse metallothionein-1 gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 29:99-108.
40. McKnight RA, Shama A, Sankaran L, Wall RJ, Hennighausen L. 1992. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A 89:6943-6947.
41. Montoliu L. 1994. Transgenic mice: Fade to grey. Curr Biol 4:1025
42. Morimura S, Suzuki T, Hochi S, Yuki A, Nomura K, Kitagawa T, Nagatsu I, Imagawa M, Muramatsu M. 1993. Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat. Proc Natl Acad Sci U S A 90:2065-2068.
43. Muglia L, Jacobson L, Dikkes P, Majzoub JA. 1995. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432.
44. Nilsson E, Lendahl U. 1993. Transient expression of a human b-actin promoter/lacZ gene introduced into mouse embryos correlates with a low degree of methylation. Mol Reprod Dev 34:149-157.
45. Norwood VF, Gomez RA. 1994. Bridging the gap between physiology and molecular biology: New approaches to perpetual questions. Am J Physiol Regul Integr Comp Physiol 267:R865-R878.
46. Oberly TD, Coursin DB, Cibla HP, Oberly LW, El-Sayyad N, Ho YS. 1993. Immunolocalization of manganese superoxide dismutase in normal and transgenic mice expressing the human enzyme. Histochem J 25:267-279.
47. Olson EN, Arnold HH, Rigby PWJ, Wold BJ. 1996. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85:1-4.
48. Pahlavani MA, Haley-Zitlin V, Richardson A. 1994. Influence of dietary restriction on gene expression: Changes in the transcription of specific genes. In: Yu BP, editor. Modulation of the Aging Process by Dietary Restriction. Boca Raton, FL: CRC Press, p 143-156.
49. Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL. 1991. Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci U S A 88:478-482.
50. Passerman RS, Fishman GI. 1994. Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest 94:2421-2425.
51. Peters J, Münter K, Bader M, Hackenthal E, Mullins JJ, Ganten D. 1993. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium. J Clin Invest 91:742-747.
52. Richardson A, Birchenall-Sparks MC. 1983. Age-related changes in protein synthesis. In: Rothstein M, editor. Biological Research in Aging. New York: Alan R. Liss, Inc. p 255-273.
53. Richardson A, Roberts MS, Rutherford MS. 1985. Aging and gene expression. In: Rothstein M, editor. Review of Biological Research in Aging. New York: Alan R. Liss, Inc. p 395-419.
54. Richardson A, Semsei I. 1987. Effect of aging on translation and transcription. In: Rothstein M, editor. Review of Biological Research in Aging. New York: Alan R. Liss, Inc. p 467-483.
55. Rudnicki MA, Braun T, Hinuma S, Jaenisch R. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390.
56. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
57. Rusconi S. 1991. Transgenic regulation in laboratory animals. Experientia 47:866-877.
58. Sands AT, Hansen TN, DeMayo FJ, Stanley LA, Xin L, Schwartz RJ. 1993. Cytoplasmic b-actin promoter produces germ cell and preimplantation embryonic transgene expression. Mol Biol Rep 34:117-126.
59. Schlager G. 1966. Systolic blood pressure in eight inbred strains of mice. Nature 212:519-520.
60. Schmidt EV, Christoph G, Zeller R, Leder P. 1990. The cytomegalovirus enhancer: A pan active control element in transgenic mice. Mol Cell Biol 4406-4411.
61. Smith GS, Walford RL, Mickey MR. 1973. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J Natl Cancer Inst 50:1195-1213.
62. Sohal RS. 1993. The free radical hypothesis of aging: An appraisal of the current status. Aging Clin Exp Res 5:3-17.
63. Staats J. 1972. Standardized nomenclature for inbred strains of mice: Fifth listing. Cancer Res 32:1609-1646.
64. Staats J. 1981. Inbred and segregating inbred strains. In: Anonymous. The Mouse in Biomedical Research. New York: Academic Press, Inc. p 177-213.
65. StC. Sinclair NR. 1995. The trouble with transgenic mice. Immunol Cell Biol 73:169-173.
66. Stevens LC. 1973. A new inbred subline of mice (129/terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst 50:235-242.
67. Stief A, Winter DM, Stratling WH, Sippel AE. 1989. A nuclear DNA attachment element mediates elevated and position-independent gene activity. Nature 341:343-345.
68. Sullivan N, Gatehouse D, Tweats D. 1993. Mutation, cancer and transgenic models: Relevance to the toxicology industry. Mutagenesis 8:167-174.
69. Swenberg JA, Koestner A, Wechsler W. 1972. The induction of tumors of the nervous system with intravenous methylnitrosourea. Lab Invest 26:74-85.
70. Talbot D, Descombes P, Schiber U. 1994. The 5′-flanking region of the rat LAP(C/EBPB) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. Nucleic Acids Res 22:756-766.
71. Thompson S, Clarke AR, Pow AM, Hooper ML, Melton DW. 1989. Germ line transmission and expression of a corrected HPRT gene product by gene targeting in embryonic stem cells. Cell 56:313-321.
72. Turrens JF, Boveris A. 1996. Gemeration of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 421-427.
73. Van Remmen H, Ward W, Sabia RV, Richardson A. 1995. Effect of age on gene expression and protein degradation. In: Masoro EJ, editor. Handbook of Physiology: Aging. New York: Oxford University Press, p 171-234.
74. Wagner J, Thiele F, Ganten D. 1995. Transgenic animals as models for human disease. Clin Exp Hypertens 17:593-605.
75. Wang Y, O'Malley B Jr., Tsai ST, O'Malley BW. 1994. A regulatory system for use in gene transfer. Proc Natl Acad Sci U S A 91:8180-8184.
76. Wurm FM, Gwinn KA, Kingston RE. 1986. Inducible overexpression of the mouse c-myc protein in mammalian cells. Proc Natl Acad Sci U S A 83:5414-5418.
77. Yamashita T, Kasai N, Miyoshi I, Sasaki N, Maki K, Sakai M, Nishi S, Namioka S. 1993. High level expression of human alpha-fetoprotein in transgenic mice. Biochem Biophys Res Commun 191:715-720.